Journal rankings · indicator year 2014
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2014
Endocrinology, Diabetes and Metabolism journal rankings 2014
136 ranked journals · Subfield in Medicine
Endocrinology, Diabetes and Metabolism has 136 ranked journals in 2014. The median OJR rose 0.10 on 2013 to 0.97, below the world average of 1.00; Q1 starts at OJR 1.50. The top three are Endocrine Reviews, Diabetes Care, and Best Practice & Research Clinical Endocrinology & Metabolism.
Ranks and citation indicators: 2014. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2011–2013, the window the 2014 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery734
- Pulmonary and Respiratory Medicine283
- Public Health, Environmental and Occupational Health244
- Cardiology and Cardiovascular Medicine227
- Oncology179
- Infectious Diseases173
- Epidemiology166
- Neurology138
- Endocrinology, Diabetes and Metabolism136
- Radiology, Nuclear Medicine and Imaging136
- Physiology127
- Psychiatry and Mental health119
Show all 42 subfields
- Orthopedics and Sports Medicine89
- Pediatrics, Perinatology and Child Health80
- Ophthalmology75
- Dermatology74
- Hematology69
- Rheumatology59
- Obstetrics and Gynecology58
- Nephrology51
- Pharmacology43
- Reproductive Medicine43
- Complementary and alternative medicine41
- Emergency Medicine36
- Geriatrics and Gerontology35
- Otorhinolaryngology34
- Rehabilitation25
- Critical Care and Intensive Care Medicine22
- Pathology and Forensic Medicine21
- Genetics19
- Hepatology18
- Immunology and Allergy16
- Anesthesiology and Pain Medicine12
- Urology12
- Gastroenterology6
- Internal Medicine5
- Transplantation3
- Family Practice2
- Health Informatics1
- Anatomy0
- Biochemistry0
- Microbiology0
136 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2013. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2011–2013, the window the 2014 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2011–2013 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2005 to 2014. | Compare |
|---|---|---|---|---|---|---|---|
1Endocrine ReviewsOxford University Press · United States | 7.48Q1 | 20.62 4.77 up from 2013 | 105 | 26% | $3,750 | ||
2Diabetes CareAmerican Diabetes Association · United States | 4.25Q1 | 9.51 0.45 up from 2013 | 1,998 | 66% | — | ||
3Best Practice & Research Clinical Endocrinology & MetabolismElsevier BV · United Kingdom | 3.30Q1 | 6.20 0.64 down from 2013 | 235 | 8% | $4,450 | ||
4The Journal of Clinical Endocrinology & MetabolismOxford University Press · United States | 3.30Q1 | 7.48 0.42 down from 2013 | 2,524 | 50% | $3,750 | ||
5Diabetes Obesity and MetabolismWiley · United Kingdom | 3.23Q1 | 8.37 0.99 up from 2013 | 537 | 27% | $5,380 | ||
6The Lancet Diabetes & EndocrinologyElsevier BV · Netherlands | 3.09Q1 | 6.71no 2013 value | 101 | 39% | $7,280 | — | |
7DiabetologiaSpringer Science+Business Media · Germany | 2.93Q1 | 7.78 0.03 down from 2013 | 1,066 | 63% | $3,490 | ||
8Reviews in Endocrine and Metabolic DisordersSpringer Science+Business Media · Netherlands | 2.74Q1 | 5.87 0.79 up from 2013 | 106 | 33% | $5,590 | ||
9Endocrinology and Metabolism Clinics of North AmericaElsevier BV · United States | 2.37Q1 | 5.45 1.01 up from 2013 | 147 | 10% | $3,540 | ||
10Journal of Internal MedicineWiley · United Kingdom | 2.37Q1 | 5.78 1.05 up from 2013 | 418 | 64% | $4,780 | ||
11Current Opinion in Endocrinology Diabetes and ObesityLippincott Williams & Wilkins · United Kingdom | 2.32Q1 | 4.69 0.40 down from 2013 | 236 | 35% | — | ||
12Current Diabetes ReportsSpringer Science+Business Media · United States | 2.25Q1 | 4.97 0.55 up from 2013 | 264 | 40% | $4,890 | ||
13European Journal of EndocrinologyOxford University Press · United Kingdom | 2.15Q1 | 5.08 0.40 up from 2013 | 741 | 23% | $4,292 | ||
14EndocrinologyOxford University Press · United States | 2.13Q1 | 5.17 0.21 down from 2013 | 1,548 | 58% | $3,750 | ||
15Endocrine Related CancerBioscientifica · United Kingdom | 2.09Q1 | 5.00 0.85 down from 2013 | 321 | 88% | — | ||
16Journal of EndocrinologyBioscientifica · United Kingdom | 2.08Q1 | 4.60 0.19 up from 2013 | 434 | 95% | — | ||
17World Journal of DiabetesOAHong Kong SAR China | 2.04Q1 | 4.49 0.18 up from 2013 | 111 | 100% | — | ||
18Cardiovascular DiabetologyOABioMed Central · United Kingdom | 1.80Q1 | 5.61 0.71 up from 2013 | 448 | 100% | $4,290 | ||
19Current Diabetes ReviewsBentham Science Publishers · Netherlands | 1.77Q1 | 3.53 0.59 down from 2013 | 163 | 12% | — | ||
20Diabetes and Vascular Disease ResearchOASAGE Publishing · United Kingdom | 1.76Q1 | 3.97 0.68 up from 2013 | 148 | 45% | $2,100 | ||
21Journal of Diabetes ResearchOAHindawi Publishing Corporation · United Kingdom | 1.71Q1 | 3.34no 2013 value | 128 | 100% | $2,760 | ||
22Diabetes/Metabolism Research and ReviewsWiley · United Kingdom | 1.70Q1 | 4.22 0.08 down from 2013 | 367 | 17% | $4,780 | ||
23Diabetes Metabolic Syndrome and ObesityOADove Medical Press · New Zealand | 1.70Q1 | 4.76 1.24 up from 2013 | 138 | 100% | $2,836 | ||
24ThyroidMary Ann Liebert, Inc. · United States | 1.65Q1 | 4.04 0.68 up from 2013 | 823 | 39% | — | ||
25Clinical Pharmacology Advances and ApplicationsOADove Medical Press · New Zealand | 1.65Q1 | 3.14 0.36 up from 2013 | 44 | 100% | $2,320 | ||
26Diabetes TherapyOAAdis, Springer Healthcare · United Kingdom | 1.65Q1 | 3.79 0.56 up from 2013 | 62 | 100% | $7,400 | ||
27Diabetic MedicineWiley · United Kingdom | 1.61Q1 | 3.72 0.01 up from 2013 | 856 | 27% | $4,870 | ||
28Diabetology & Metabolic SyndromeOABioMed Central · United Kingdom | 1.59Q1 | 3.76 0.17 up from 2013 | 172 | 100% | $2,890 | ||
29Clinical EndocrinologyWiley · United Kingdom | 1.58Q1 | 3.61 0.29 up from 2013 | 931 | 26% | $4,250 | ||
30The Review of Diabetic StudiesOAGermany | 1.56Q1 | 2.12 0.75 down from 2013 | 82 | 100% | — | ||
31Nutrition Metabolism and Cardiovascular DiseasesElsevier BV · Italy | 1.54Q1 | 3.28 0.36 down from 2013 | 402 | 22% | $3,000 | ||
32MaturitasElsevier BV · Netherlands | 1.54Q1 | 3.64 0.03 down from 2013 | 588 | 23% | $4,390 | ||
33Diabetes Research and Clinical PracticeElsevier BV · Netherlands | 1.51Q1 | 3.53 0.09 down from 2013 | 923 | 9% | $4,410 | ||
34Diabetes & MetabolismElsevier BV · Netherlands | 1.50Q1 | 3.30 0.06 down from 2013 | 253 | 1% | $4,490 | ||
35Therapeutic Advances in Endocrinology and MetabolismOASAGE Publishing · United Kingdom | 1.48Q2 | 3.64 1.92 up from 2013 | 51 | 100% | $2,650 | ||
36Lipids in Health and DiseaseOABioMed Central · United Kingdom | 1.46Q2 | 3.25 0.07 down from 2013 | 614 | 100% | $2,990 | ||
37Journal of Diabetes and its ComplicationsElsevier BV · United States | 1.45Q2 | 3.41 0.86 up from 2013 | 291 | 24% | $3,760 | ||
38Diabetes & Metabolism JournalOAKorean Diabetes Association · South Korea | 1.44Q2 | 3.77 0.98 up from 2013 | 233 | 100% | $500 | ||
39International Journal of EndocrinologyOAHindawi Publishing Corporation · United Kingdom | 1.39Q2 | 3.08 0.43 up from 2013 | 380 | 100% | $2,830 | ||
40Clinical TherapeuticsElsevier BV · United States | 1.39Q2 | 3.07 0.13 down from 2013 | 660 | 40% | $4,240 | ||
41Diabetes Technology & TherapeuticsMary Ann Liebert, Inc. · United States | 1.33Q2 | 2.92 0.35 down from 2013 | 539 | 45% | — | ||
42Journal of Thyroid ResearchHindawi Publishing Corporation · United Kingdom | 1.32Q2 | 2.69 0.30 down from 2013 | 133 | 100% | $950 | ||
43Pediatric DiabetesWiley · Denmark | 1.32Q2 | 3.57 1.13 up from 2013 | 297 | 63% | $2,740 | ||
44Endocrine PracticeElsevier BV · United States | 1.32Q2 | 2.78 0.16 down from 2013 | 600 | 9% | $3,480 | ||
45Menopause The Journal of The North American Menopause SocietyLippincott Williams & Wilkins · United States | 1.29Q2 | 3.45 0.40 up from 2013 | 672 | 23% | — | ||
46Chronic IllnessSAGE Publishing · United Kingdom | 1.26Q2 | 1.87 0.25 down from 2013 | 80 | 39% | $4,150 | ||
47BMC Endocrine DisordersOABioMed Central · United Kingdom | 1.25Q2 | 2.82 0.01 up from 2013 | 111 | 100% | $3,190 | ||
48Endocrine ConnectionsOABioscientifica · United Kingdom | 1.23Q2 | 2.57 1.57 up from 2013 | 51 | 100% | $2,146 | ||
49The Science of Diabetes Self-Management and CareSAGE Publishing · United States | 1.23Q2 | 2.41 0.11 down from 2013 | 186 | 39% | $4,400 | ||
50Expert Review of Clinical PharmacologyTaylor & Francis · United Kingdom | 1.21Q2 | 2.54 0.01 down from 2013 | 198 | 20% | — |
Subfields of Medicine, with Endocrinology, Diabetes and Metabolism highlighted.
- Surgery734
- Pulmonary and Respiratory Medicine283
- Public Health, Environmental and Occupational Health244
- Cardiology and Cardiovascular Medicine227
- Oncology179
- Infectious Diseases173
- Epidemiology166
- Neurology138
- Endocrinology, Diabetes and Metabolism136
- Radiology, Nuclear Medicine and Imaging136
- Physiology127
- Psychiatry and Mental health119
- Orthopedics and Sports Medicine89
- Pediatrics, Perinatology and Child Health80
- Ophthalmology75
- Dermatology74
- Hematology69
- Rheumatology59
- Obstetrics and Gynecology58
- Nephrology51
- Pharmacology43
- Reproductive Medicine43
- Complementary and alternative medicine41
- Emergency Medicine36
- Geriatrics and Gerontology35
- Otorhinolaryngology34
- Rehabilitation25
- Critical Care and Intensive Care Medicine22
- Pathology and Forensic Medicine21
- Genetics19
- Hepatology18
- Immunology and Allergy16
- Anesthesiology and Pain Medicine12
- Urology12
- Gastroenterology6
- Internal Medicine5
- Transplantation3
- Family Practice2
- Health Informatics1
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2014. Corpus-wide, 77.7% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
44 additional Endocrinology, Diabetes and Metabolism journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2011–2013, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2014. Publication window: 2011–2013. How these summaries are calculated
- Ranked journals
- 136
- Window papers (baseline)
- 58,424 +8.4% from indicator year 2011
- Median OJR
- 0.97 +1.3% from indicator year 2011
- Rising journals (2025)
- 11
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2011–2013 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 48 | 51 | 57 | 60 | 65 | 70 | 78 | 84 | 89 | 95 | 101 | 111 | 124 | 132 | 136 | 141 | 151 | 156 | 162 | 168 | 161 | 163 | 159 | 159 | 157 | 152 | |
| Window papers (baseline) | 21,857 | 24,171 | 25,806 | 27,521 | 27,880 | 30,069 | 32,732 | 36,738 | 40,740 | 46,752 | 50,540 | 53,888 | 54,290 | 56,103 | 58,424 | 61,715 | 64,393 | 66,581 | 68,391 | 70,385 | 72,729 | 75,894 | 79,750 | 82,000 | 83,560 | 87,039 | |
| Median OJR | 0.50 | 0.65 | 0.69 | 0.77 | 0.71 | 0.81 | 0.84 | 0.94 | 0.91 | 0.93 | 1.01 | 0.959 | 0.98 | 0.868 | 0.97 | 0.957 | 0.951 | 0.893 | 0.950 | 0.86 | 0.954 | 0.8896 | 0.8903 | 0.9170 | 0.9165 | 0.870 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.